Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-024119
Filing Date
2025-02-20
Accepted
2025-02-20 16:00:55
Documents
120
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bbio-20241231.htm   iXBRL 10-K 6713322
2 EX-10.42 bbio-ex10_42.htm EX-10.42 24671
3 EX-21 bbio-ex21.htm EX-21 49947
4 EX-23.1 bbio-ex23_1.htm EX-23.1 10894
5 EX-31.1 bbio-ex31_1.htm EX-31.1 23685
6 EX-31.2 bbio-ex31_2.htm EX-31.2 23692
7 EX-31.3 bbio-ex31_3.htm EX-31.3 23118
8 EX-32.1 bbio-ex32_1.htm EX-32.1 9736
9 EX-32.2 bbio-ex32_2.htm EX-32.2 9865
10 EX-32.3 bbio-ex32_3.htm EX-32.3 9031
11 GRAPHIC img30636631_0.jpg GRAPHIC 15800
12 GRAPHIC img188918214_0.jpg GRAPHIC 262026
13 GRAPHIC img188918214_1.jpg GRAPHIC 41707
14 GRAPHIC img188918214_2.jpg GRAPHIC 20150
15 GRAPHIC img188918214_3.jpg GRAPHIC 32560
16 GRAPHIC img188918214_4.jpg GRAPHIC 204585
17 GRAPHIC img188918214_5.jpg GRAPHIC 110413
  Complete submission text file 0000950170-25-024119.txt   27676728

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bbio-20241231.xsd EX-101.SCH 3045423
123 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20241231_htm.xml XML 5403974
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38959 | Film No.: 25645155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)